Search

everythinglearnresearchcommunity

for

Search:↓

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

New regenerative treatments for hair loss show promise but need more research for confirmation.

New cancer treatments aim to reduce side effects and improve effectiveness.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Low BMI and cold exposure increase the risk of chilblains.

Prurigo pigmentosa mainly affects middle-aged White and Asian women, often linked to a ketogenic diet, and is best treated with oral antibiotics.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Scaffold-based strategies show promise for regenerating hair follicles and teeth but need more research for clinical use.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Some therapies using stem cells and platelet-rich plasma may help treat osteoarthritis, but more research is needed to ensure they are safe and effective.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

A boy with Sjogren-Larsson syndrome has skin and muscle symptoms due to a specific enzyme deficiency.

The same genetic mutation in Sjögren-Larsson syndrome can lead to different levels of severity, suggesting other factors influence the symptoms.